From the Department of Medical Imaging, The Ottawa Hospital, University of Ottawa, 1053 Carling Ave, Ottawa, ON, Canada K1H 1H6 (N.S.); Departments of Radiology (M.S.D., N.E.C.) and Urology (M.S.D.), Michigan Medicine, University of Michigan, Ann Arbor, Mich; Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women's College Hospital, University of Toronto, Toronto, ON, Canada (S.K.); Department of Radiology, University of Nebraska Medical Center, Omaha, Neb (E.A.E.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (I.P.); Department of Radiology, New York University Langone Medical Center, New York, NY (N.H.); Department of Radiology and Diagnostic Imaging, Hospital Israelita Albert Einstein, São Paulo, Brazil (R.H.B.); Department of Radiology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Mass (A.S.); and Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (S.G.S.).
Radiographics. 2021 May-Jun;41(3):814-828. doi: 10.1148/rg.2021200160. Epub 2021 Apr 16.
Cystic renal masses are commonly encountered in clinical practice. In 2019, the Bosniak classification of cystic renal masses, originally developed for CT, underwent a major revision to incorporate MRI and is referred to as the Bosniak Classification, version 2019. The proposed changes attempt to define renal masses (ie, cystic tumors with less than 25% enhancing tissue) to which the classification should be applied; emphasize specificity for diagnosis of cystic renal cancers, thereby decreasing the number of benign and indolent cystic masses that are unnecessarily treated or imaged further; improve interobserver agreement by defining imaging features, terms, and classes of cystic renal masses; reduce variation in reported malignancy rates for each of the Bosniak classes; incorporate MRI and to some extent US; and be applicable to all cystic renal masses encountered in clinical practice, including those that had been considered indeterminate with the original classification. The authors instruct how, using CT, MRI, and to some extent US, the revised classification can be applied, with representative clinical examples and images. Practical tips, pitfalls to avoid, and decision tree rules are included to help radiologists and other physicians apply the Bosniak Classification, version 2019 and better manage cystic renal masses. An online resource and mobile application are also available for clinical assistance. RSNA, 2021.
囊性肾肿块在临床实践中很常见。2019 年,Bosniak 分类法对囊性肾肿块进行了重大修订,最初是为 CT 开发的,现在纳入了 MRI,并称为 Bosniak 分类法,2019 年版。提出的更改旨在定义应应用该分类的肾肿块(即增强组织少于 25%的囊性肿瘤);强调对囊性肾癌的诊断特异性,从而减少不必要治疗或进一步成像的良性和惰性囊性肿块数量;通过定义囊性肾肿块的影像学特征、术语和类别来提高观察者间的一致性;减少每个 Bosniak 类别报告的恶性率差异;纳入 MRI,并在一定程度上纳入 US;并适用于临床实践中遇到的所有囊性肾肿块,包括那些用原始分类法被认为不确定的肿块。作者通过 CT、MRI(在一定程度上还有 US)指导如何应用修订后的分类法,并提供了有代表性的临床示例和图像。包括实用技巧、避免的陷阱和决策树规则,以帮助放射科医生和其他医生应用 Bosniak 分类法,2019 年版,并更好地管理囊性肾肿块。还提供了在线资源和移动应用程序,以提供临床帮助。RSNA,2021 年。